1. Home
  2. TELA vs GECC Comparison

TELA vs GECC Comparison

Compare TELA & GECC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TELA
  • GECC
  • Stock Information
  • Founded
  • TELA 2012
  • GECC 2016
  • Country
  • TELA United States
  • GECC United States
  • Employees
  • TELA N/A
  • GECC N/A
  • Industry
  • TELA Medical/Dental Instruments
  • GECC Finance: Consumer Services
  • Sector
  • TELA Health Care
  • GECC Finance
  • Exchange
  • TELA Nasdaq
  • GECC Nasdaq
  • Market Cap
  • TELA 112.5M
  • GECC 121.9M
  • IPO Year
  • TELA 2019
  • GECC N/A
  • Fundamental
  • Price
  • TELA $2.69
  • GECC $10.69
  • Analyst Decision
  • TELA Strong Buy
  • GECC
  • Analyst Count
  • TELA 4
  • GECC 0
  • Target Price
  • TELA $9.25
  • GECC N/A
  • AVG Volume (30 Days)
  • TELA 178.1K
  • GECC 29.5K
  • Earning Date
  • TELA 11-07-2024
  • GECC 02-27-2025
  • Dividend Yield
  • TELA N/A
  • GECC 13.56%
  • EPS Growth
  • TELA N/A
  • GECC N/A
  • EPS
  • TELA N/A
  • GECC 0.65
  • Revenue
  • TELA $68,649,000.00
  • GECC $39,468,000.00
  • Revenue This Year
  • TELA $30.39
  • GECC $17.68
  • Revenue Next Year
  • TELA $25.51
  • GECC $4.96
  • P/E Ratio
  • TELA N/A
  • GECC $16.43
  • Revenue Growth
  • TELA 29.34
  • GECC 16.86
  • 52 Week Low
  • TELA $2.30
  • GECC $9.55
  • 52 Week High
  • TELA $7.84
  • GECC $11.31
  • Technical
  • Relative Strength Index (RSI)
  • TELA 40.76
  • GECC 56.34
  • Support Level
  • TELA $2.66
  • GECC $10.02
  • Resistance Level
  • TELA $2.88
  • GECC $10.80
  • Average True Range (ATR)
  • TELA 0.18
  • GECC 0.33
  • MACD
  • TELA -0.02
  • GECC 0.01
  • Stochastic Oscillator
  • TELA 21.19
  • GECC 62.96

About TELA TELA Bio Inc.

TELA Bio Inc is a United States-based medical technology company. The company is involved in developing and marketing of tissue reinforcement materials to address unmet needs in soft tissue reconstruction. Its reinforced tissue matrices called OviTex improve the clinical outcomes and reduce costs of care in hernia repair, abdominal wall reconstruction and plastic and reconstructive surgery. The company's second portfolio of products, the OviTex PRS Reinforced Tissue Matrix, addresses unmet needs in plastic and reconstructive surgery.

About GECC Great Elm Capital Corp.

Great Elm Capital Corp is an externally managed, non-diversified closed-end management investment company. The company seeks to generate current income and capital appreciation through debt and equity investments, including investments in specialty finance businesses. It invests in senior secured and senior unsecured debt instruments, as well as in junior loans and mezzanine debt of middle-market companies and small businesses. The company generates revenue from interest on the debt investments that it holds.

Share on Social Networks: